163 related articles for article (PubMed ID: 8558198)
1. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
Majlis A; Smith TL; Talpaz M; O'Brien S; Rios MB; Kantarjian HM
J Clin Oncol; 1996 Jan; 14(1):196-203. PubMed ID: 8558198
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Rios MB; Majlis A; Keating M; Freireich EJ; Kantarjian H
J Clin Oncol; 1998 Oct; 16(10):3279-85. PubMed ID: 9779702
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
Medina J; Kantarjian H; Talpaz M; O'Brien S; Garcia-Manero G; Giles F; Rios MB; Hayes K; Cortes J
Cancer; 2003 Nov; 98(9):1905-11. PubMed ID: 14584073
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia.
Przepiorka D; Thomas ED
Bone Marrow Transplant; 1988 Mar; 3(2):113-9. PubMed ID: 3048475
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
6. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
[TBL] [Abstract][Full Text] [Related]
8. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
[TBL] [Abstract][Full Text] [Related]
9. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
13. Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Shah NK; Wagner J; Santos G; Griffin CA
Cancer Genet Cytogenet; 1992 Jul; 61(2):183-92. PubMed ID: 1638501
[TBL] [Abstract][Full Text] [Related]
14. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.
Fayad L; Kantarjian H; O'Brien S; Seong D; Albitar M; Keating M; Talpaz M
Leukemia; 1997 May; 11(5):767-71. PubMed ID: 9180306
[TBL] [Abstract][Full Text] [Related]
15. [Chronic myeloid leukemia. Karyotype changes].
Rojas-Atencio A; Pineda-Del Villar L; Avila-León E; González-Ferrer S; Prieto-Carrasquero M; Soto M; González R
Invest Clin; 1996 Sep; 37(3):167-75. PubMed ID: 8983354
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
[TBL] [Abstract][Full Text] [Related]
17. Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia.
Chase A; Pickard J; Szydlo R; Coulthard S; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2000 Mar; 27(3):278-84. PubMed ID: 10679917
[TBL] [Abstract][Full Text] [Related]
18. Isodicentric Philadelphia chromosome in accelerated phase of chronic myeloid leukemia.
Pernice F; Squadrito G; Saitta A; Mazza G; Musolino C
Cancer Genet Cytogenet; 1993 Apr; 66(2):113-6. PubMed ID: 8500097
[TBL] [Abstract][Full Text] [Related]
19. Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia.
Kloke O; Niederle N; Qiu JY; Wandl U; Moritz T; Nagel-Hiemke M; Hawig I; Opalka B; Seeber S; Becher R
Br J Haematol; 1993 Mar; 83(3):399-403. PubMed ID: 8485045
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
Kantarjian HM; Smith TL; O'Brien S; Beran M; Pierce S; Talpaz M
Ann Intern Med; 1995 Feb; 122(4):254-61. PubMed ID: 7825760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
